CoChat

Management of Helicobacter pylori eradication – the influence of structured counselling and follow‐up

Open access
Al‐Eidan, F. A., McElnay, J. C., Scott, M. G., McConnell, J. B. · 2002 · British Journal of Clinical Pharmacology
Cited by 99

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Aims Helicobacter pylori(H. pylori) eradication rate varies according to the treatment regimen used and other factors, e.g. antimicrobial resistance and patient compliance. The aim of the present study was to evaluate the influence of patient counselling and follow‐up on H. pylori eradication rates and to document the effectiveness of a 1 week eradication regimen consisting of lansoprazole (30 mg once daily), amoxicillin (1 g twice daily) and clarithromycin (500 mg twice daily). Methods Seventy‐six dyspeptic patients, who at endoscopy were found to have gastritis, duodenitis or ulceration, and a positive H. pylori urease test, were recruited. Patients were randomly assigned to an intervention group (n = 38) or a control group (n = 38). Intervention patients received their medicines via the hospital pharmacy and were counselled (and followed up) by a hospital pharmacist. Control patients were given a standard advice sheet and referred to their GP who prescribed the same therapy. Results Intervention patients exhibited a statistically significant improvement in the H. pylori eradication rate (94.7%vs 73.7%;P = 0.02) and compliance (92.1%vs 23.7;P < 0.001). Of the 64 H. pylori eradicated patients, 62 were able to eliminate their antisecretory medication compared with only 12 of the H. pylori persistent patients (P < 0.001). A pharmacoeconomic evaluation indicated that counselling and follow‐up reduced the direct costs of eradication by approximately £30 per patient. Conclusions Structured patient counselling and follow‐up can have a significant effect on H. pylori eradication rates and should be a routine part of therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.0306-5251.2001.01531.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 99

Metadata

Authors
Al‐Eidan, F. A., McElnay, J. C., Scott, M. G., & McConnell, J. B.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2002-01-18
Volume
53
Issue
2
Pages
163-171
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W1883517927
Cited by
99
References
2
FWCI
3.63
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of Helicobacter pylori eradication – the influence of structured counselling and follow‐up. https://app.cochat.ai/papers/10.1046/j.0306-5251.2001.01531.x
The paper
Al‐Eidan, F. A., McElnay, J. C., Scott, M. G., & McConnell, J. B. (2002). Management of Helicobacter pylori eradication – the influence of structured counselling and follow‐up. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.0306-5251.2001.01531.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.